A new study published in Experimental Eye Research reported that the preclinical results achieved with SPG302 (Spinogenix, Inc.) “provide initial proof of concept that synaptic regeneration may offer a new approach to treating…
Preclinical study suggests synaptic regeneration may offer new pathway to treat glaucoma | Ophthalmology Times
